The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

From persistent fevers to unexplained weight loss, discover the subtle HIV symptoms doctors say you shouldn't ignore, ...

Analysts at RBC Capital Markets have predicted twice-yearly lenacapavir could become a $2 billion product, and become a key ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government ...

In the rural villages of South Africa, U.S. President Donald Trump’s sudden freeze on foreign aid impacts hundreds of ...

Understand how drug use increases HIV risk and learn about prevention strategies that save lives. Medical experts explain ...

The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...

The U.S. decision in January to freeze all funding for U.S. foreign assistance, including for the U.S. President's Emergency ...

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...